PDC*line Pharma will be presenting a poster at the ESMO Annual Meeting 2022
We are thrilled to announce that PDC*line Pharma will be presenting a poster at the ESMO - European Society for Medical Oncology Annual Meeting 2022 taking place from 9 to 13 September 2022, in Paris, France. The poster will highlight clinical results from patients enrolled in the three first cohorts of the on-going Phase I/II trial evaluating PDC*lung01, an 'off-the-shelf' cancer vaccine for the treatment of patients with non-small cell lung cancer (NSCLC).
Title: Open-label, dose escalation, Phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-Programmed Death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC).
Presentation Number: 1176P
Presenter: Johan F. Vansteenkiste Department of Respiratory Oncology, University Hospitals KU Leuven, Belgium
Date: Mon, 12.09.2022
Link to the abstract: https://cslide.ctimeetingtech.com/esmo2022/attendee/confcal_2/presentation/list?q=1176P&r=pt%7E17
The poster will be available on the Publications section of pdc-line-pharma.com following the presentation.
About ESMO
ESMO is the leading professional organisation for medical oncology. With more than 25,000 members representing oncology professionals from over 160 countries worldwide, ESMO is the society of reference for oncology education and information.
